Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tango Therapeutics Inc
(NQ:
TNGX
)
9.540
+0.160 (+1.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
982,032
Open
9.450
Bid (Size)
7.920 (12)
Ask (Size)
10.00 (1)
Prev. Close
9.380
Today's Range
9.030 - 9.720
52wk Range
2.880 - 13.03
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
May 24, 2024
Via
Benzinga
Performance
YTD
-4.41%
-4.41%
1 Month
+24.38%
+24.38%
3 Month
+17.06%
+17.06%
6 Month
-6.01%
-6.01%
1 Year
+172.57%
+172.57%
More News
Read More
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
Tango Therapeutics Announces Discontinuation of TNG348 Program
May 23, 2024
From
Tango Therapeutics
Via
Business Wire
Recap: Tango Therapeutics Q4 Earnings
March 18, 2024
Via
Benzinga
Tango Therapeutics: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 08, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 18, 2024
Via
InvestorPlace
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
March 18, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tango Therapeutics to Participate in Upcoming Investor Conferences
March 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Pancreatic Cancer Treatments Poised for Major Advances in 2024
February 07, 2024
Via
FinancialNewsMedia
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
October 17, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 09, 2023
Via
Benzinga
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 13, 2023
Via
Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
October 09, 2023
Via
The Motley Fool
Chart Of The Day: Tango Therapeutics - What Happens When The FDA Gives A Thumbs UP!
October 06, 2023
Via
Talk Markets
Exposures
Product Safety
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 12, 2023
Via
Benzinga
Why Shares of Tango Therapeutics Climbed This Week
September 14, 2023
Via
The Motley Fool
Exposures
Product Safety
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 12, 2023
Via
Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
Via
Benzinga
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed
August 31, 2023
Via
Benzinga
Topics
ETFs
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.